share_log

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(4.4%),Daniel B. Asher(4.4%), etc.

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals

Aslan Pharmaceuticals | SC 13G:超過5%持股股東披露文件
美股sec公告 ·  03/21 16:47
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息